Dr Lin Zhu
People_

Dr Lin Zhu

Research Fellow, Sydney School of Public Health
Dr Lin Zhu

Lin Zhu is a research fellow and biostatistician at the Sydney School of Public Health. His research interests are in evaluating the long-term effects of interventions, particularly for the primary prevention of cardiovascular disease. He is also interested in improving the risk prediction tools that are central to effective decision-making. He is currently working on a project aimming to identify the health inequities among various ethnic groups in Australia.

  • Survival Analysis
  • Causal Inference
  • Data Linkage
  • Clinical Epidemiology
  • Causal Inference
  • Introduction to Epidemiology and Biostatistics

'Ethnicity and cardiovascular health in New South Wales'. This project is using linked data to examine ethnic inequalities in the incidence, prognosis and evidence-based management of cardiovascular disease.

International Society For Clinical Biostatistics (ISCB)
Australasian Epidemiological Association (AEA)
Australasian Epidemiological Association (AEA)International Society For Clinical Biostatistics (ISCB)
Australasian Epidemiological Association (AEA)International Society For Clinical Biostatistics (ISCB)
Australasian Epidemiological Association (AEA)Australasian Epidemiological Association (AEA)

EMCR Boost Scheme Award (USYD)

Australian Government Research Training Program (UTS)

Project titleResearch student
Ethnic inequalities in COVID-19 and cardiovascular diseasePeiyao XU

Publications

Journals

  • Zhu, L., Hayen, A., Blanch, B., Engstrom, N., Doust, J., Semsarian, C., Bell, K. (2024). First implantable cardiac defibrillator insertions in New South Wales, 2005–2020: an analysis of linked administrative data. Medical Journal of Australia, 220(5), 249-257. [More Information]
  • Zhu, L., Bell, K., Hayen, A. (2023). Methods to address selection bias in post-trial studies of legacy effects were evaluated. Journal of Clinical Epidemiology, 160, 110-116. [More Information]
  • Bell, K., White, S., Hassan, O., Zhu, L., Scott, A., Clark, J., Glasziou, P. (2022). Evaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment: A Systematic Review and Meta-analysis. JAMA Internal Medicine, 182(6), 634-642. [More Information]

2024

  • Zhu, L., Hayen, A., Blanch, B., Engstrom, N., Doust, J., Semsarian, C., Bell, K. (2024). First implantable cardiac defibrillator insertions in New South Wales, 2005–2020: an analysis of linked administrative data. Medical Journal of Australia, 220(5), 249-257. [More Information]

2023

  • Zhu, L., Bell, K., Hayen, A. (2023). Methods to address selection bias in post-trial studies of legacy effects were evaluated. Journal of Clinical Epidemiology, 160, 110-116. [More Information]

2022

  • Bell, K., White, S., Hassan, O., Zhu, L., Scott, A., Clark, J., Glasziou, P. (2022). Evaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment: A Systematic Review and Meta-analysis. JAMA Internal Medicine, 182(6), 634-642. [More Information]
  • Bell, K., Zhu, L., Glasziou, P. (2022). Keeping Score-Appropriate and Timely Use of CACS-Reply. JAMA Internal Medicine, 182(11), 1233-1234. [More Information]
  • Gregory, G., Zhu, L., Hayen, A., Bell, K. (2022). Learning from the pandemic: Mortality trends and seasonality of deaths in Australia in 2020. International Journal of Epidemiology, 51(3), 718-726. [More Information]

2021

  • Zhu, L., Bell, K., Nayak, A., Hayen, A. (2021). A methods review of posttrial follow-up studies of cardiovascular prevention finds potential biases in estimating legacy effects. Journal of Clinical Epidemiology, 131, 51-58. [More Information]

2020

  • Zhu, L., Hayen, A., Bell, K. (2020). Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study. Cardiovascular Diabetology, 19(1), 28. [More Information]